Yun Zhao

Nanjing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

Incidence and prevalence of inflammatory Bowel disease in China: a regional population-based study from 2020 to 2022.

Incidence and prevalence of inflammatory Bowel disease in China: a regional population-based study from 2020 to 2022.

Journal: Scandinavian journal of gastroenterology
Published: May 12, 2026

[Gly2]-GLP-2(1-5): An ultra-short GLP-2 peptide for intestinal mucosal protection in inflammatory bowel disease.

[Gly2]-GLP-2(1-5): An ultra-short GLP-2 peptide for intestinal mucosal protection in inflammatory bowel disease.

Journal: Peptides
Published: April 15, 2026

Macrophage MERTK restrains GRAMD1A-driven mitochondrial oxysterol trafficking to limit colitis.

Macrophage MERTK restrains GRAMD1A-driven mitochondrial oxysterol trafficking to limit colitis.

Journal: Redox biology
Published: March 10, 2026

Danthron Attenuates Intestinal Inflammation by Modulating Oxidative Stress via the EGFR-PI3K-AKT and Nrf2-HO-1 Pathways.

Danthron Attenuates Intestinal Inflammation by Modulating Oxidative Stress via the EGFR-PI3K-AKT and Nrf2-HO-1 Pathways.

Journal: Antioxidants (Basel, Switzerland)
Published: December 15, 2025

Application of multilayer drug-loaded hydrogels in protection of open abdomen wounds.

Application of multilayer drug-loaded hydrogels in protection of open abdomen wounds.

Journal: RSC advances
Published: December 08, 2025

Prevalence, risk factors, and clinical outcomes of extraintestinal manifestations in inflammatory bowel disease: a population-based study in china.

Prevalence, risk factors, and clinical outcomes of extraintestinal manifestations in inflammatory bowel disease: a population-based study in china.

Journal: European journal of gastroenterology & hepatology
Published: November 07, 2025

Mechanism of Gzma-mediated GEF-H1 activation in intestinal epithelial cells leading to intestinal barrier dysfunction in sepsis.

Mechanism of Gzma-mediated GEF-H1 activation in intestinal epithelial cells leading to intestinal barrier dysfunction in sepsis.

Journal: Clinical and translational medicine
Published: October 29, 2025

4-octyl itaconate inhibits cytokine-mediated inflammation via alkylation of TYK2 and JAK1.

4-octyl itaconate inhibits cytokine-mediated inflammation via alkylation of TYK2 and JAK1.

Journal: Cell reports
Published: October 29, 2025

STING-ERO1 signaling exacerbates PARylation-mediated parthanatos in sepsis.

STING-ERO1 signaling exacerbates PARylation-mediated parthanatos in sepsis.

Journal: Cell communication and signaling : CCS
Published: July 17, 2025

GEF-H1 upon microtubule destabilization drives ZBP1-dependent necroptosis.

GEF-H1 upon microtubule destabilization drives ZBP1-dependent necroptosis.

Journal: Cell death and differentiation
Published: June 14, 2025

STING inhibitors and degraders: Potential therapeutic agents in inflammatory diseases.

STING inhibitors and degraders: Potential therapeutic agents in inflammatory diseases.

Journal: European journal of medicinal chemistry
Published: February 17, 2025

Gasdermin B modulates intestinal epithelial homeostasis via regulating hyperactive unfolded protein response in Crohn's disease.

Gasdermin B modulates intestinal epithelial homeostasis via regulating hyperactive unfolded protein response in Crohn's disease.

Journal: Journal of Crohn's & colitis
Published: January 20, 2025
Showing 1-12 of 42

Last Updated: 09/26/2026